Loading…
Mamu-B17 + Rhesus Macaques Vaccinated with env , vif , and nef Manifest Early Control of SIVmac239 Replication
Certain major histocompatibility complex class I (MHC-I) alleles are associated with spontaneous control of viral replication in human immunodeficiency virus (HIV)-infected people and simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs). These cases of "elite" control of HIV/...
Saved in:
Published in: | Journal of virology 2018-08, Vol.92 (16) |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Certain major histocompatibility complex class I (MHC-I) alleles are associated with spontaneous control of viral replication in human immunodeficiency virus (HIV)-infected people and simian immunodeficiency virus (SIV)-infected rhesus macaques (RMs). These cases of "elite" control of HIV/SIV replication are often immune-mediated, thereby providing a framework for studying anti-lentiviral immunity. In this study, we examined how vaccination impacts SIV replication in RMs expressing the MHC-I allele
Approximately 21% of
and 50% of
RMs control chronic-phase viremia after SIVmac239 infection. Because CD8
T cells targeting Mamu-B*08-restricted SIV epitopes have been implicated in virologic suppression in
RMs, we investigated whether this might also be true for
RMs. Two groups of
RMs were vaccinated with genes encoding Mamu-B*17-restricted epitopes in Vif and Nef. These genes were delivered by themselves (group 1) or together with
(group 2). Group 3 included MHC-I-matched RMs and served as the control group. Surprisingly, the group 1 vaccine regimen had little effect on viral replication compared to group 3, suggesting that unlike
RMs, preexisting SIV-specific CD8
T cells alone do not facilitate long-term virologic suppression in
RMs. Remarkably, however, 5/8 group 2 vaccinees controlled viremia to |
---|---|
ISSN: | 0022-538X 1098-5514 1098-5514 |
DOI: | 10.1128/JVI.00690-18 |